Giffin Daughtridge (2020) “The Time is Now for Disruptive Innovation in Pre-Exposure Prophylaxis Adherence Monitoring”, HIV/AIDS Research and Treatment, 7(1), pp. 5–9. doi: 10.17140/HARTOJ-7-133.